ITMI20050891A1 - Formulazioni per il trattamento di psoriasi - Google Patents

Formulazioni per il trattamento di psoriasi

Info

Publication number
ITMI20050891A1
ITMI20050891A1 IT000891A ITMI20050891A ITMI20050891A1 IT MI20050891 A1 ITMI20050891 A1 IT MI20050891A1 IT 000891 A IT000891 A IT 000891A IT MI20050891 A ITMI20050891 A IT MI20050891A IT MI20050891 A1 ITMI20050891 A1 IT MI20050891A1
Authority
IT
Italy
Prior art keywords
psoriasis
formulations
treatment
Prior art date
Application number
IT000891A
Other languages
English (en)
Italian (it)
Inventor
Nicola Nardiello
Original Assignee
Greenleaf S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greenleaf S R L filed Critical Greenleaf S R L
Priority to IT000891A priority Critical patent/ITMI20050891A1/it
Priority to PCT/EP2006/004373 priority patent/WO2006122685A1/fr
Priority to EP06753546A priority patent/EP1881833A1/fr
Publication of ITMI20050891A1 publication Critical patent/ITMI20050891A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
IT000891A 2005-05-17 2005-05-17 Formulazioni per il trattamento di psoriasi ITMI20050891A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT000891A ITMI20050891A1 (it) 2005-05-17 2005-05-17 Formulazioni per il trattamento di psoriasi
PCT/EP2006/004373 WO2006122685A1 (fr) 2005-05-17 2006-05-10 Compositions destinees a traiter le psoriasis
EP06753546A EP1881833A1 (fr) 2005-05-17 2006-05-10 Compositions destinees a traiter le psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000891A ITMI20050891A1 (it) 2005-05-17 2005-05-17 Formulazioni per il trattamento di psoriasi

Publications (1)

Publication Number Publication Date
ITMI20050891A1 true ITMI20050891A1 (it) 2006-11-18

Family

ID=36763953

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000891A ITMI20050891A1 (it) 2005-05-17 2005-05-17 Formulazioni per il trattamento di psoriasi

Country Status (3)

Country Link
EP (1) EP1881833A1 (fr)
IT (1) ITMI20050891A1 (fr)
WO (1) WO2006122685A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2959415B1 (fr) 2010-04-30 2012-07-13 Ayawane Composition dermatologique a base d'huile d'argan et d'acide hyaluronique.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB643690A (en) * 1947-08-18 1950-09-27 Lilly Co Eli Improvements in or relating to a process of preparing a vitamin preparation and the product resulting therefrom
GB662485A (en) * 1948-08-27 1951-12-05 Lilly Co Eli Improvements in or relating to method of stabilizing vitamin solutions and the stabilized vitamin solutions resulting from said method
US3011944A (en) * 1956-07-21 1961-12-05 Zh Nagao Kenkyusho Composition for eliminating toxic effects of nicotine and method of using same
US3080292A (en) * 1960-07-12 1963-03-05 Hoffmann La Roche Stable pleasant-tasting vitamin b containing beadlets
FR4492M (fr) * 1965-07-07 1966-10-10
JPS62258313A (ja) * 1986-05-02 1987-11-10 Segawa Hiroki 化粧料
JP3103396B2 (ja) * 1990-07-20 2000-10-30 武田薬品工業株式会社 浴用剤
JPH0985161A (ja) * 1995-09-28 1997-03-31 Kiteii:Kk 物質の被覆方法
CA2178790A1 (fr) * 1996-06-11 1997-12-12 Daniel L. Baier Produit pour soigner l'erytheme du siege
NZ299412A (en) * 1996-09-19 1998-12-23 Al Sari Mishal Hamid Pharmaceutical compositions comprising a medicament derived from the leaves and flowers of nerrium oleander
US6107349A (en) * 1998-04-16 2000-08-22 Mantynen; Philip R. Method and composition for treating psoriasis
JP2002003377A (ja) * 2000-06-20 2002-01-09 Taisho Pharmaceut Co Ltd ピコスルファートナトリウム配合緩下剤
DE10053155A1 (de) * 2000-10-26 2002-05-08 Erika Jungkeit Verwendung eines Multivitaminpräparats zur Behandlung der Schuppenflechte
ITBS20010027A1 (it) * 2001-03-23 2002-09-23 Gen Topics Srl Principio attivo a base di acido lipoico ed acidi grassi polienolici
ES2342409T3 (es) * 2004-01-30 2010-07-06 Biotie Therapies Oyj Composiciones utiles especialmente para el tratamiento o prevencion del sindrome metabolico.

Also Published As

Publication number Publication date
WO2006122685A1 (fr) 2006-11-23
EP1881833A1 (fr) 2008-01-30

Similar Documents

Publication Publication Date Title
IL277406A (en) A new use for IL-1 beta compounds
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
DK1988877T3 (da) Terapeutiske sammensætninger omfattende ingenol-3-angelat
DK1868586T3 (da) Antiinflammatorisk formulering
ITMO20050195A1 (it) Macchina per il trattamento extracorporeo di sangue
CY2018006I1 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
ITMI20031311A0 (it) Formulazioni per il trattamento di disturbi artrosici
ITRM20050179A1 (it) Composizione impiegabile per il trattamento delle patologie paradontali.
ITMI20050891A1 (it) Formulazioni per il trattamento di psoriasi
EP1901765A4 (fr) Traitement intralésionnel du psoriasis
ITMI20041941A1 (it) Processo per la preparazione di lisofosfatidilcoline
ITMI20062049A1 (it) Apparecchiatura per il trattamento di alimenti
ITMI20052464A1 (it) Procedimento per la preparazi9one di norelgestromin norelgestromina
ITMI20040452A1 (it) Processo per la preparazione di oxcarbazepina
ITMI20041086A1 (it) Procedimento per la preparazione di idrocarbilalogenuri
ITMI20052419A1 (it) Processo per la preparazione di carbotioati androstanici
DK1594498T3 (da) Anvendelse af etazolat til behandling af sygdomme
FI20051058A0 (fi) Menetelmä puhtaiden enantiomeerien valmistukseen
ITMI20040726A1 (it) Procedimento per la preparazione di melatonina
ITMI20040003A1 (it) Processo per la preparazione di 6-fluoro-2-metil-1-indanone
SE0400574D0 (sv) A novel pharmaceutical composition for the treatment of psoriasis
ITMI20040528A1 (it) Dispositivo emettitore di stimoli luminosi per il trattamento di disturbi psicofisici
ITGE20050087A1 (it) Metodologia per la preparazione di un trattamento superidrofobico
ITVR20050140A1 (it) Struttura di tramezzo
ITVR20050133A1 (it) Struttura di monile